Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

6773 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
90-21 德力静 DAIICHI SANKYO CO., LTD. Original drug imported to China Original drug imported to China The 90th Batch of Reference Listed Drugs
90-22 / GE Healthcare Shanghai Co., Ltd. Drug manufactured in China by overseas originator companies Localization of original drug The 90th Batch of Reference Listed Drugs
90-23 / GE Healthcare Shanghai Co., Ltd. Drug manufactured in China by overseas originator companies Localization of original drug The 90th Batch of Reference Listed Drugs
90-24 / GE Healthcare Shanghai Co., Ltd. Drug manufactured in China by overseas originator companies Localization of original drug The 90th Batch of Reference Listed Drugs
90-25 / GE Healthcare Shanghai Co., Ltd. Drug manufactured in China by overseas originator companies Localization of original drug The 90th Batch of Reference Listed Drugs
90-26 DHIVY AVION PHARMACEUTICALS LLC Original drug not imported to China US Orange Book The 90th Batch of Reference Listed Drugs
90-27 PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER BAXTER HEALTHCARE CORP Original drug not imported to China US Orange Book The 90th Batch of Reference Listed Drugs
90-28 XHANCE OPTINOSE US INC Original drug not imported to China US Orange Book The 90th Batch of Reference Listed Drugs
90-29 / ZYDUS PHARMACEUTICALS USA INC Internationally recognized to be equivalent to the original drug US Orange Book The 90th Batch of Reference Listed Drugs
90-30 TLANDO Verity Pharmaceuticals Inc. Original drug not imported to China US Orange Book The 90th Batch of Reference Listed Drugs